Summary of Novanta Inc. (NOVT) Q4 2025 Earnings Call

1Key Financial Results and Metrics:

Q4 Revenue: $250 million, representing a 9% growth year-over-year, with 2% organic growth and 4% sequential growth.

Full Year Revenue: $981 million, marking the highest annual revenue in the company's history.

Bookings: Increased by 25% year-over-year and 12% sequentially, with a book-to-bill ratio of 1.11.

Adjusted EBITDA: $61 million for Q4, up 17% year-over-year, with a margin of 23.5%.

Adjusted EPS: $0.91 for Q4, a 20% increase year-over-year; $3.29 for the full year, a 7% increase.

Gross Margin: 45.5% for Q4, down from 47% year-over-year; full-year gross margin at 46%.

Operating Cash Flow: $9 million in Q4, down from $62 million in the prior year; full-year cash flow at $64 million.

Debt Position: Gross debt of $260 million with a net cash position of negative $121 million.

2Strategic Updates and Business Highlights:

Growth Strategy: Focus on high-growth markets such as AI-driven robotics, minimally invasive surgery, and precision medicine, with a long-term goal of achieving mid-single-digit organic growth.

Acquisition Pipeline: Over $1.5 billion in acquisition capacity, with a strong pipeline targeting medical technologies and embedded software.

Product Performance: New product sales grew over 80% year-over-year in Q4, contributing to a vitality index of 24% of sales.

Market Dynamics: Strong performance in advanced surgery, robotics, and automation, with significant design wins and customer partnerships.

3Forward Guidance and Outlook:

2026 Revenue Guidance: Expected GAAP revenue between $1,030 million and $1,050 million, indicating 4% to 6% organic growth.

Q1 2026 Guidance: Projected revenue of $250 million to $255 million, with organic growth of 1% to 3%.

Gross Margin Target: Expected to improve to approximately 47% for the full year 2026.

Operating Cash Flow Guidance: Projected to rebound to $145 million to $185 million for 2026.

4Bad News, Challenges, or Points of Concern:

Margin Compression: Gross margins fell below expectations due to prioritizing customer deliveries over manufacturing transfers, leading to higher dual running costs and increased inventory.

Cash Flow Issues: Operating cash flow was significantly impacted by regional manufacturing dynamics and inventory builds.

Dilution from Equity Fundraise: The recent equity offering will create a headwind of $0.22 to $0.24 per share on EPS due to an increased share count.

5Notable Q&A Insights:

Bookings Growth: All business segments reported double-digit bookings growth, with broad-based momentum across the company.

Automation Enabling Technologies: Significant growth attributed to advancements in robotics and automation, particularly in semiconductor applications and AI-driven technologies.

Keyon Acquisition: Outperformed expectations, contributing $9 million in incremental revenue, with a mix of project-based and recurring revenue streams.

Market Positioning: The company is well-positioned in the robotics and automation sector, with unique capabilities in drilling GPU boards, indicating a strong growth trajectory in this area. In conclusion, Novanta Inc. demonstrated robust growth in Q4 2025, with a strong outlook for 2026 driven by strategic initiatives and a solid acquisition pipeline, despite facing challenges related to margin compression and cash flow dynamics.